Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
Abstract Long-term effects of continuous subcutaneous apomorphine infusion (CSAI) on health-related quality of life (HRQoL) and predictors of CSAI discontinuation are poorly known. Data from consecutive advanced Parkinson’s disease patients treated in routine care were retrospectively collected over...
Main Authors: | Bruna Meira, Bertrand Degos, Elise Corsetti, Mohamed Doulazmi, Emeline Berthelot, Clara Virbel-Fleischman, Pauline Dodet, Aurélie Méneret, Louise-Laure Mariani, Cécile Delorme, Florence Cormier-Dequaire, David Bendetowicz, Nicolas Villain, Clément Tarrano, Lise Mantisi, Hélène Letrillart, Céline Louapre, Eavan McGovern, Yulia Worbe, David Grabli, Marie Vidailhet, Elodie Hainque, Emmanuel Roze |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00194-7 |
Similar Items
-
Explicit Agency in Patients with Cervical Dystonia: Altered Recognition of Temporal Discrepancies between Motor Actions and Their Feedback.
by: Cécile Delorme, et al.
Published: (2016-01-01) -
Subcortical Myoclonus and Associated Dystonia in 22q11.2 Deletion Syndrome
by: Vincent Van Iseghem, et al.
Published: (2020-01-01) -
Apomorphine effects on the hippocampus
by: Luis Enrique Arroyo-Garcia, et al.
Published: (2018-01-01) -
Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine
by: J.N. Picada, et al.
Published: (2005-04-01) -
Effects of Apomorphine on the Activity of Neuron
by: Wen-Chuan Hsiao, et al.
Published: (2002)